2-Methacryloyloxyethyl Phosphorylcholine: Enhancing Biocompatibility and Brain Delivery of Therapeutics

Discover how site-oriented conjugation of MPC polymers offers a breakthrough in delivering therapeutic antibodies to the brain, preserving their efficacy and paving the way for advanced treatments.

Get a Quote & Sample

Advantages Provided by the Product

Enhanced Biocompatibility

MPC polymers are renowned for their exceptional biocompatibility, minimizing rejection and adverse reactions when used in medical devices and drug delivery systems, which is crucial for long-term patient safety.

Improved Therapeutic Efficacy

By facilitating targeted delivery, especially across the blood-brain barrier, MPC conjugation can significantly boost the efficacy of therapeutic agents, leading to better patient outcomes.

Preserved Biofunctionality

Unlike some other encapsulation methods, site-oriented MPC conjugation effectively preserves the crucial biological functions and binding affinities of therapeutic molecules, such as antibodies.

Key Applications

Therapeutic Antibody Delivery

MPC polymers are instrumental in developing antibody delivery systems that can effectively cross the blood-brain barrier, targeting neurological diseases like brain tumors or neurodegenerative conditions.

Biodevices

The antifouling properties of MPC polymers make them ideal for coating medical implants and biosensors, preventing nonspecific protein adsorption and ensuring device longevity and accuracy.

Biomaterials

MPC-based materials offer excellent blood compatibility and tissue compatibility, making them suitable for a wide range of biomedical applications where minimizing inflammatory responses is critical.

Drug Delivery Systems

MPC polymers serve as advanced carriers for various drug molecules, improving their solubility, stability, and targeted delivery, thereby enhancing therapeutic outcomes.